Comparison of Fused Diffusion-Weighted Imaging Using Unenhanced MRI and Abbreviated Post-Contrast-Enhanced MRI in Patients with Breast Cancer
Authors:
- Kyeyoung LeeKLKyeyoung Lee
- Yeo Jin JeongYJYeo Jin Jeong
- Ki Seok ChooKCKi Seok Choo
- Su Bong NamSNSu Bong Nam
- Hyun Yul KimHKHyun Yul Kim
- Youn Joo JungYJYoun Joo Jung
- Seung Ju LeeSLSeung Ju Lee
- Ji Hyeon JooJJJi Hyeon Joo
- Jin You KimJKJin You Kim
- Jin Joo KimJKJin Joo Kim
- Jee Yeon KimJKJee Yeon Kim
- Mi Sook YunMYMi Sook Yun
Open Access
Abstract
Background and Objectives: To determine the percentage of breast cancers detectable by fused diffusion-weighted imaging (DWI) using unenhanced magnetic resonance imaging (MRI) and abbreviated post-contrast-enhanced MRI. Materials and Methods: Between October 2016 and October 2017, 194 consecutive women (mean age, 54.2 years; age range, 28–82 years) with newly diagnosed unilateral breast cancer, who underwent preoperative 3.0 T breast MRI with DWI, were evaluated. Both fused DWI and abbreviated MRI were independently reviewed by two radiologists for the detection of index cancer (which showed the most suspicious findings in both breasts), location, lesion conspicuity, lesion type, and lesion size. Moreover, the relationship between cancer detection and histopathological results of surgical specimens was evaluated. Results: Index cancer detection rates were comparable between fused DWI and abbreviated MRI (radiologist 1: 174/194 [89.7%] vs. 184/194 [94.8%], respectively, p = 0.057; radiologist 2: 174/194 [89.7%] vs. 183/194 [94.3%], respectively, p = 0.092). In both radiologists, abbreviated MRI showed a significantly higher lesion conspicuity than fused DWI (radiologist 1: 9.37 ± 2.24 vs. 8.78 ± 3.03, respectively, p < 0.001; radiologist 2: 9.16 ± 2.32 vs. 8.39 ± 2.93, respectively, p < 0.001). The κ value for the interobserver agreement of index cancer detection was 0.67 on fused DWI and 0.85 on abbreviated MRI. For lesion conspicuity, the intraclass correlation coefficients were 0.72 on fused DWI and 0.82 on abbreviated MRI. Among the histopathological factors, tumor invasiveness was associated with cancer detection on both fused DWI (p = 0.011) and abbreviated MRI (p = 0.004, radiologist 1), lymphovascular invasion on abbreviated MRI (p = 0.032, radiologist 1), and necrosis on fused DWI (p = 0.031, radiologist 2). Conclusions: Index cancer detection was comparable between fused DWI and abbreviated MRI, although abbreviated MRI showed a significantly better lesion conspicuity.Keywords
This publication has 38 references indexed in Scilit:
- Conspicuity of breast lesions at different b values on diffusion-weighted imagingBMC Cancer, 2012
- Diffusion‐weighted MRI as an adjunct to mammography in women under 50 years of age: An initial studyJournal of Magnetic Resonance Imaging, 2012
- Diffusion-weighted MRI: influence of intravoxel fat signal and breast density on breast tumor conspicuity and apparent diffusion coefficient measurementsMagnetic Resonance Imaging, 2011
- Contribution of Diffusion-Weighted Imaging to Dynamic Contrast-Enhanced MRI in the Characterization of Breast TumorsAmerican Journal of Roentgenology, 2011
- Meta-analysis of quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesionsBMC Cancer, 2010
- Detection of non-palpable breast cancer in asymptomatic women by using unenhanced diffusion-weighted and T2-weighted MR imaging: comparison with mammography and dynamic contrast-enhanced MR imagingEuropean Radiology, 2010
- Apparent Diffusion Coefficient Values for Discriminating Benign and Malignant Breast MRI Lesions: Effects of Lesion Type and SizeAmerican Journal of Roentgenology, 2010
- Body Diffusion-Weighted MR Imaging Using High b-Value for Malignant Tumor Screening: Usefulness and Necessity of Referring to T2-Weighted Images and Creating Fusion ImagesAcademic Radiology, 2007
- Quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesionEuropean Radiology, 2007
- Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinomaEuropean Journal of Cancer, 2006